Sentence examples for date of the documentation from inspiring English sources

the date of the documentation as "still alive" at the last available time point.

Disease free survival (DFS) was defined as the time from the date of diagnosis to the date of the documentation of relapse, including locoregional recurrence and/or distant metastasis.

Disease free survival (DFS) was defined as the time in months from the date of biopsy to the first documented recurrence during the follow up or the date of the final documentation.

The duration of response was defined as the time from the date of the first documentation of objective response (i.e., CR or PR) to the date of the first documentation of PD.

Progression-free survival was defined as the time from the date of registration to the date of the first documentation of disease progression (by imaging methods or clinical judgment) or death.

The primary end point is DFS, defined as the time from the date of randomization to the date of the first documentation of re-occurrence of invasive breast cancer in local, regional, or distant sites; new invasive breast cancer in the contralateral breast; or death from any cause.

PFS was defined as the time from the date of initial treatment to the date of the first objective documentation of PD or death.

The CRF served as the patient's study record and included a log of all contacts with research staff, all completed telephone surveys, the survey booklet completed by the patient on the date of the intervention, and documentation of payment for study participation.

The time to tumor progression (TTP) was determined by the interval between the initiation of treatment and the date of first documentation of disease progression or the date of death from any cause.

Time to treatment failure was defined as the time from the date of randomization to the date of first documentation of disease progression, symptomatic deterioration, death from any cause, or discontinuation of treatment due to AE, refusal, or other reason.

PFS was calculated from the date of first dose of study drug administered until the date of first documentation of recurrence/progression or death due to any cause; patients were otherwise censored at the last evaluation.